S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
S&P 500   3,269.96 (-1.21%)
DOW   26,501.60 (-0.59%)
QQQ   269.38 (-2.54%)
AAPL   108.86 (-5.60%)
MSFT   202.47 (-1.10%)
FB   263.11 (-6.31%)
GOOGL   1,616.11 (+3.80%)
AMZN   3,036.15 (-5.45%)
TSLA   388.04 (-5.55%)
NVDA   501.36 (-3.76%)
BABA   304.69 (-2.52%)
CGC   18.78 (+0.00%)
GE   7.42 (+0.68%)
MU   50.34 (-0.28%)
AMD   75.29 (-3.50%)
T   27.02 (+0.97%)
F   7.73 (-2.15%)
ACB   4.05 (-0.98%)
GILD   58.15 (-0.65%)
NIO   30.58 (-4.41%)
NFLX   475.74 (-5.65%)
BA   144.39 (-2.63%)
DIS   121.25 (-0.24%)
Log in
NYSE:FMS

Fresenius Medical Care AG & Co. Stock Forecast, Price & News

$38.23
-0.83 (-2.12 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$37.99
Now: $38.23
$38.72
50-Day Range
$39.06
MA: $41.90
$43.19
52-Week Range
$29.17
Now: $38.23
$46.55
Volume216,102 shs
Average Volume294,086 shs
Market Capitalization$22.39 billion
P/E Ratio15.80
Dividend Yield1.28%
Beta1.26
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2018, it operated 3,928 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Read More
Fresenius Medical Care AG & Co. logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 1.9Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.77 out of 5 stars

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone49-6172-608-2522
Employees120,659

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.58 billion
Cash Flow$5.12 per share
Book Value$24.83 per share

Profitability

Net Income$1.34 billion

Miscellaneous

Market Cap$22.39 billion
Next Earnings DateN/A
OptionableOptionable
$38.23
-0.83 (-2.12 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Fresenius Medical Care AG & Co. (NYSE:FMS) Frequently Asked Questions

How has Fresenius Medical Care AG & Co.'s stock been impacted by COVID-19 (Coronavirus)?

Fresenius Medical Care AG & Co.'s stock was trading at $35.43 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FMS shares have increased by 7.9% and is now trading at $38.23.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Fresenius Medical Care AG & Co.?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. in the last year. There are currently 3 hold ratings, 9 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Fresenius Medical Care AG & Co.
.

How were Fresenius Medical Care AG & Co.'s earnings last quarter?

Fresenius Medical Care AG & Co. (NYSE:FMS) posted its earnings results on Sunday, November, 1st. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.54 by $0.06. Fresenius Medical Care AG & Co. had a return on equity of 10.50% and a net margin of 7.26%.
View Fresenius Medical Care AG & Co.'s earnings history
.

How often does Fresenius Medical Care AG & Co. pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. announced an annual dividend on Thursday, August 13th. Shareholders of record on Monday, August 31st will be paid a dividend of $0.7073 per share on Friday, September 11th. This represents a dividend yield of 1.64%. The ex-dividend date is Friday, August 28th. This is a positive change from Fresenius Medical Care AG & Co.'s previous annual dividend of $0.66.
View Fresenius Medical Care AG & Co.'s dividend history
.

What price target have analysts set for FMS?

13 equities research analysts have issued 12-month target prices for Fresenius Medical Care AG & Co.'s shares. Their forecasts range from $42.00 to $48.00. On average, they expect Fresenius Medical Care AG & Co.'s share price to reach $45.13 in the next year. This suggests a possible upside of 18.0% from the stock's current price.
View analysts' price targets for Fresenius Medical Care AG & Co.
.

Are investors shorting Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 397,500 shares, a decline of 15.0% from the September 30th total of 467,800 shares. Based on an average trading volume of 145,200 shares, the short-interest ratio is presently 2.7 days.
View Fresenius Medical Care AG & Co.'s Short Interest
.

Who are some of Fresenius Medical Care AG & Co.'s key competitors?

What other stocks do shareholders of Fresenius Medical Care AG & Co. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. investors own include Energy Transfer (ET), Petra Diamonds Limited (PDL.L) (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

Who are Fresenius Medical Care AG & Co.'s key executives?

Fresenius Medical Care AG & Co.'s management team includes the following people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57)

What is Fresenius Medical Care AG & Co.'s stock symbol?

Fresenius Medical Care AG & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co.'s major shareholders?

Fresenius Medical Care AG & Co.'s stock is owned by many different retail and institutional investors. Top institutional shareholders include Crossmark Global Holdings Inc. (0.01%), Envestnet Asset Management Inc. (0.01%), Meyer Handelman Co. (0.00%), Atlas Capital Advisors LLC (0.00%), Altfest L J & Co. Inc. (0.00%) and OLD National Bancorp IN (0.00%).

Which institutional investors are selling Fresenius Medical Care AG & Co. stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including Meyer Handelman Co., Crossmark Global Holdings Inc., James Investment Research Inc., and Altfest L J & Co. Inc..

Which institutional investors are buying Fresenius Medical Care AG & Co. stock?

FMS stock was bought by a variety of institutional investors in the last quarter, including OLD National Bancorp IN, Pacer Advisors Inc., Atlas Capital Advisors LLC, NEXT Financial Group Inc, Nachman Norwood & Parrott Inc, and Envestnet Asset Management Inc..

How do I buy shares of Fresenius Medical Care AG & Co.?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fresenius Medical Care AG & Co.'s stock price today?

One share of FMS stock can currently be purchased for approximately $38.23.

How big of a company is Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. has a market capitalization of $22.39 billion and generates $19.58 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $2.53 on an earnings per share basis. Fresenius Medical Care AG & Co. employs 120,659 workers across the globe.

What is Fresenius Medical Care AG & Co.'s official website?

The official website for Fresenius Medical Care AG & Co. is www.freseniusmedicalcare.com.

How can I contact Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co.'s mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-608-2522 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.